Atlas FDA

DirectFlow arterial cannula is intended to deliver oxygenated blood for cardiopulmonary bypass during surgery. The produ

FDA device recall Z-0309-04 · posted 2004-01-09 · Terminated

Recall details

Recalling firm
Heartport Inc
Reason for recall
Damaged hemostasis valves that prevent or present difficulty when inserting catheters.
Action taken
Recall was first initiated on/about 10/2/03 by phone domestically from the Director of Marketing to the firm''s Sales Force (no phone script available). Following the initial phone call, formal recall letters were sent out on 10/6/03 to: Director of CV Suite; Director of the OR; and Director of Material Management of each hospital.
Root cause
Other
Status
Terminated
Product code
DWF
Quantity affected
151 units
Distribution
Products were distributed domestically to 45 customers in CA, DC, FL, GA, IN, MD, MI, MN, MO, NC, NJ, NY, OH, PA, SC, TN, TX, VA, WA, and WI. The products were also distributed internationally to Isra
Date initiated
2003-10-02
Date posted
2004-01-09
Date terminated
2005-10-19
Location
Somerville, NJ

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
VACLOK SYRINGE (K994253)Merit Medical Systems, Inc.2000-01-05
DIRECTFLOW ARTERIAL CANNULA (K990772)Heartport, Inc.1999-03-23
HEARTPORT DIRECT AORTIC RETURN CANNULA WITH INTRODUCER (K974736)Heartport, Inc.1998-07-15
HEARTPORT INTRODUCER SHEATH (K972570)Heartport, Inc.1997-10-01
HEARTPORT ENDOARTERIAL RETURN CANNULA (K971291)Heartport, Inc.1997-06-17
HEARTPORT ENDOARTERIAL RETURN CANNUAL (K955121)Heartport, Inc.1996-05-10